Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27400293 | 0.92 | ALDH1A1 (0.55) | KMT2AALDH1A1TDP1MAOALMNA | |
| SCHEMBL29026626 | 0.88 | PPID (0.43) | KMT2AMEN1ALDH1A1CYP3A4TSHR | |
| SCHEMBL147245 | 0.84 | KMT2A (0.44) | KMT2AMEN1ALDH1A1CYP3A4TDP1 | |
| SCHEMBL25448604 | 0.84 | KMT2A (0.44) | KMT2AMEN1ALDH1A1CYP3A4TDP1 | |
| SCHEMBL1561073 | 0.84 | ALDH1A1 (0.45) | KMT2AMEN1ALDH1A1CYP3A4TDP1 | |
| SCHEMBL6453211 | 0.83 | ALDH1A1 (0.47) | KMT2AMEN1ALDH1A1CYP3A4TDP1 | |
| SCHEMBL2511445 | 0.83 | ALDH1A1 (0.64) | KMT2AMEN1ALDH1A1CYP3A4TDP1 | |
| SCHEMBL27353978 | 0.83 | APP (0.44) | KMT2AMEN1ALDH1A1CYP3A4TDP1 | |
| SCHEMBL4509522 | 0.83 | ALDH1A1 (0.64) | KMT2AMEN1ALDH1A1CYP3A4TDP1 | |
| SCHEMBL28625515 | 0.82 | KMT2A (0.52) | KMT2AMEN1ALDH1A1CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125418-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | OWLSTONE MED LTD (GB) | 2026-05-07 | — | — | US | claimed |
| EP-4598592-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | Owlstone Medical Limited (GB) | 2025-08-13 | — | — | EP | claimed |
| CN-120152745-A | Compounds and their use for detecting diseases in exhaled breath of a subject | 奥斯通医疗有限公司 | 2025-06-13 | — | — | CN | claimed |
| WO-2025031383-A1 | BIFUNCTIONAL LINKER COMPOUND, ANTIBODY DRUG CONJUGATE, PREPARATION METHOD FOR ANTIBODY DRUG CONJUGATE, AND USE OF ANTIBODY DRUG CONJUGATE | 杭州爱科瑞思生物医药有限公司 | 2025-02-13 | — | — | WO | claimed |
| WO-2024074813-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | OWLSTONE MEDICAL LIMITED (GB) | 2024-04-11 | — | — | WO | claimed |
| CN-117069793-A | Bifunctional linker compound, antibody drug conjugate, and preparation methods and applications thereof | 杭州爱科瑞思生物医药有限公司 | 2023-11-17 | — | — | CN | claimed |
| EP-4079316-A1 | PROCOAGULANT COMPOUNDS | Bioverativ Therapeutics Inc. (US) | 2022-10-26 | — | — | EP | claimed |
| US-20220243189-A1 | PROCOAGULANT COMPOUNDS | BIOGEN MA INC. | 2022-08-04 | — | — | US | claimed |
| EP-3693000-B1 | PROCOAGULANT COMPOUNDS | BIOVERATIV THERAPEUTICS INC (US) | 2022-03-02 | — | — | EP | claimed |
| EP-3693000-A1 | PROCOAGULANT COMPOUNDS | Bioverativ Therapeutics Inc. (US) | 2020-08-12 | — | — | EP | claimed |
| WO-2015187540-A1 | PEPTIDE-DRUG CONJUGATES | CHU SHAOSONG (US) | 2015-12-10 | — | — | WO | claimed |
| US-20150343083-A1 | PEPTIDE-DRUG CONJUGATES | JIARAY PHARMACEUTICALS, INC. (KY) | 2015-12-03 | — | — | US | claimed |
| US-20150328330-A1 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-11-19 | — | — | US | claimed |
| US-9095618-B2 | Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-08-04 | — | — | US | claimed |
| US-20150184142-A1 | PROCOAGULANT COMPOUNDS | BIOGEN IDEC MA INC. (US) | 2015-07-02 | — | — | US | claimed |
| US-20140134111-A1 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-05-15 | — | — | US | claimed |
| US-8658149-B2 | Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-02-25 | — | — | US | claimed |
| US-20110142764-A1 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2011-06-16 | — | — | US | claimed |
| EP-2303288-A2 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | Ramot at Tel-Aviv University Ltd. (IL) | 2011-04-06 | — | — | EP | claimed |
| WO-2009141823-A2 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-11-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150328330-A1 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | VEGFA, BPGM, SOST | KMT2A 4124/4885MEN1 1384/4885ALDH1A1 2685/4885 |
| US-20260125418-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | BRCA1, L3MBTL1, LMNA | KMT2A 3488/4885MEN1 35/4885ALDH1A1 1039/4885 |
| US-20220243189-A1 | PROCOAGULANT COMPOUNDS | PLG, F2, PLAT | KMT2A 3722/4885MEN1 1483/4885ALDH1A1 4124/4885 |
| US-20150184142-A1 | PROCOAGULANT COMPOUNDS | PLG, F2, PLAT | KMT2A 3722/4885MEN1 1483/4885ALDH1A1 4124/4885 |
| US-20150343083-A1 | PEPTIDE-DRUG CONJUGATES | DNPEP, VIP, PEPD | KMT2A 3657/4885MEN1 482/4885ALDH1A1 3736/4885 |
| US-20140134111-A1 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | VEGFA, BPGM, SOST | KMT2A 4124/4885MEN1 1384/4885ALDH1A1 2685/4885 |
| US-20110142764-A1 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES | VEGFA, BPGM, SOST | KMT2A 4124/4885MEN1 1384/4885ALDH1A1 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.